ℹ️
🇬🇧
Search
Search for publications relevant for "thiosemicarbazone"
thiosemicarbazone
Publication
Class
Person
Publication
Programmes
publication
Thiosemicarbazones of acetylpyrazines as potential drugs I.
2002 |
Publication without faculty affiliation
publication
Thiosemicarbazones and their antimycobacterial effects
2013 |
Faculty of Pharmacy in Hradec Králové
publication
Thiosemicarbazones of acetylpyrazines as potential antifungal and antituberculous drugs II.
Publication without faculty affiliation
publication
Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity
2008 |
First Faculty of Medicine
publication
Investigation of the Biological Properties of (Hetero)Aromatic Thiosemicarbazones
2012 |
Faculty of Medicine in Hradec Králové
publication
Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: Cellular iron chelation mediating cytotoxic activity
2008 |
Central Library of Charles University
publication
Preparation of Tryptanthrin Derivates Bearing a Thiosemicarbazone Moiety to Inhibit SARS-CoV-2 Replication
2023 |
First Faculty of Medicine
publication
Thiosemicarbazones of acetylpyrazines as potential drugs
Publication without faculty affiliation
publication
Thiosemicarbazones of acetylpyrazines: Preparation and their hydrophobic properties
2005 |
Central Library of Charles University, Faculty of Pharmacy in Hradec Králové
publication
Exploring the Anti-Cancer Activity of Novel Thiosemicarbazones Generated through the Combination of Retro-Fragments: Dissection of Critical Structure-Activity Relationships
2014 |
Faculty of Pharmacy in Hradec Králové
publication
HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents
2009 |
Central Library of Charles University
publication
Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity
+1
2008 |
Faculty of Medicine in Hradec Králové
publication
Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: Cellular iron chelation mediating cytotoxic activity
2008 |
Central Library of Charles University, Faculty of Pharmacy in Hradec Králové
publication
LC-MS/MS identification of the principal in vitro and in vivo phase I metabolites of the novel thiosemicarbazone anti-cancer drug, Bp4eT
2012 |
Faculty of Pharmacy in Hradec Králové
publication
Synthesis and antifungal screening of 2-{[1-(5-alkyl/arylalkylpyrazin-2-yl)ethylidene]hydrazono}-1,3-thiazolidin-4-ones
2016 |
Central Library of Charles University, Faculty of Pharmacy in Hradec Králové
publication
Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents
2015 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
Identification of in vitro metabolites of the novel anti-tumor thiosemicarbazone, DpC, using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry
2013 |
Faculty of Pharmacy in Hradec Králové
publication
3-[(E)-(acridin-9 '-ylmethylidene)amino]-1-substituted thioureas and their biological activity
2017 |
Publication without faculty affiliation
publication
HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents
2009 |
Faculty of Pharmacy in Hradec Králové
publication
Novel SPME fibers based on a plastic support for determination of plasma protein binding of thiosemicarbazone metal chelators: a case example of DpC, an anti-cancer drug that entered clinical trials
2019 |
Faculty of Pharmacy in Hradec Králové
publication
Simultaneous determination of the novel thiosemicarbazone anti-cancer agent, Bp4eT, and its main phase I metabolites in plasma: Application to a pilot pharmacokinetic study in rats
2014 |
Faculty of Pharmacy in Hradec Králové
publication
Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative Activities
2018 |
Faculty of Pharmacy in Hradec Králové
publication
In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites
2015 |
Faculty of Pharmacy in Hradec Králové
publication
Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles
+1
2008 |
Faculty of Medicine in Hradec Králové
publication
Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles
2008 |
First Faculty of Medicine
publication
Novel polymer vectors of Cu-64
2009 |
Faculty of Science
publication
Novel Derivatives of Benfluron and Dimefluron: Synthesis and Anticancer activity
2015 |
Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
publication
Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells
2022 |
First Faculty of Medicine